🔗 Permalink

Inventor profile of:

David BIKARD

City:

Paris

Country:

France

Published Applications:

Last publication date:

2026-02-12

Top Assignees for applications by David BIKARD

The entities that hold a legal rights for patent applications filed by inventor BIKARD David:

THE ROCKEFELLER UNIVERSITY 9 New York, NY United States
Institut Pasteur 8 Paris, France
Eligo Bioscience 6 Paris, France
The Rockfeller University 2 New York, NY United States
Assistance Publique-Hopitaux De Paris 1 Paris, France
FONDATION IMAGINE 1 Paris, France
UNIVERSITE PARIS CITE 1 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 1 Paris, France

Recent patent applications by BIKARD David

David BIKARD from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-12

US20260043172A1

Chemistry; metallurgy

METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY IN CRISPR-ASSOCIATED GENES

#2 | 2025-08-07

US20250249078A1

Human necessities

SEQUENCE SPECIFIC ANTIMICROBIALS

#3 | 2024-07-04

US20240218380A1

Chemistry; metallurgy

OPTIMIZED VECTOR FOR DELIVERY IN MICROBIAL POPULATIONS

#4 | 2024-06-06

US20240182886A1

Chemistry; metallurgy

METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY

#5 | 2024-05-23

US20240165210A1

Human necessities

Sequence specific antimicrobials

#6 | 2022-11-03

US20220347271A1

Human necessities

Sequence-specific antimicrobials by blocking DNA repair

#7 | 2022-07-14

US20220218797A1

Human necessities

Sequence specific antimicrobials

#8 | 2022-07-14

US20220218796A1

Human necessities

Sequence specific antimicrobials

#9 | 2022-07-14

US20220218795A1

Human necessities

Sequence specific antimicrobials

#10 | 2022-05-12

US20220143154A1

Human necessities

Sequence specific antimicrobials

#11 | 2021-12-09

US20210380993A1

Chemistry; metallurgy

Optimized vector for delivery in microbial populations

#12 | 2021-10-21

US20210322525A9

Human necessities

Sequence specific antimicrobials

#13 | 2021-06-24

US20210193259A1

Physics

METHOD, DEVICE, AND COMPUTER PROGRAM FOR GENERATING PROTEIN SEQUENCES WITH AUTOREGRESSIVE NEURAL NETWORKS

#14 | 2021-06-03

US20210162022A1

Human necessities

Sequence specific antimicrobials

#15 | 2021-03-04

US20210060141A1

Human necessities

Sequence specific antimicrobials

#16 | 2021-03-04

US20210060140A1

Human necessities

Sequence specific antimicrobials

#17 | 2020-12-24

US20200399645A1

Chemistry; metallurgy

Optimized vector for delivery in microbial populations

#18 | 2020-09-10

US20200282027A1

Human necessities

SEQUENCE SPECIFIC ANTIMICROBIALS

#19 | 2020-09-10

US20200282026A1

Human necessities

Sequence specific antimicrobials

#20 | 2020-08-06

US20200248192A1

Chemistry; metallurgy

Optimized vector for delivery in microbial populations

#21 | 2020-05-28

US20200165600A1

Chemistry; metallurgy

SYNTHETIC ATTC RECOMBINATION SITES FOR PROTEIN DOMAIN SHUFFLING

#22 | 2020-04-23

US20200121768A1

Human necessities

Sequence-specific antimicrobials by blocking DNA repair

#23 | 2020-02-06

US20200040346A1

Chemistry; metallurgy

Optimized vector for delivery in microbial populations

#24 | 2019-12-05

US20190367867A1

Chemistry; metallurgy

Method of culturing segmented filamentous bacteria in vitro

#25 | 2019-10-31

US20190330606A1

Chemistry; metallurgy

Compositions and methods using Cas9 with enhanced spacer acquisition function

#26 | 2018-07-19

US20180200342A1

Human necessities

IMPROVING SEQUENCE-SPECIFIC ANTIMICROBIALS BY BLOCKING DNA REPAIR

InventorID:

2244419 ⎘